Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a "successful couple," but are they still relevant together?

Leuk Lymphoma. 2015 Feb;56(2):275-6. doi: 10.3109/10428194.2014.946026. Epub 2014 Aug 20.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male